May 26, 2023 Basel, May 26, 2023 - The European Medicines Agency s Committee for Medicinal Products for Human Use has recommended the revocation of the conditional. | May 26, 2023
By Cecilia Butini Novartis AG on Tuesday posted slightly higher net profit and sales for the first quarter of the year, beating analysts expectations, and raised its guidance for the full. | April 25, 2023
By Cristina Roca Novartis AG said late Friday that the U.S. Food & Drug Administration has approved Scemblix for two indications in chronic myeloid leukemia. The Swiss. | November 1, 2021